Genome-wide Analysis of Myelodysplastic Syndromes
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3163-3169
Author(s):
Masashi Sanada and Seishi Ogawa
Ibubrofen in the Treatment of Patent Ductus Arteriosus in Preterm Infants: What We Know, What We Still Do Not Know
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3007-3018
Author(s):
Isabelle Mercanti, Isabelle Ligi, Farid Boubred, Isabelle Grandvuillemin, Christophe Buffat, Laurance Fayol, Veronique Millet and Umberto Simeoni
Recent Patents Related to Phosphorylation Signaling Pathway on Cancer
Journal:
Recent Patents on DNA & Gene Sequences
Volume:
5
Page:
175-184
Author(s):
Karina B. Acosta, Maria M. Tibolla, Maria M. Tiscornia, Maria A. Lorenzati and Pedro D. Zapata
Treatment of Choroidal Neovascularization in High Myopia
Journal:
Current Drug Targets
Volume:
11
Page:
630-644
Author(s):
Javier A. Montero and Jose M. Ruiz-Moreno
Protein Tyrosine Phosphatases, New Targets for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
519-532
Author(s):
David Easty, William Gallagher and D. C. Bennett
Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Journal:
Current Drug Targets
Volume:
8
Page:
217-235
Author(s):
M. A. Morgan, A. Ganser and C. W. M. Reuter
Ribosomal Proteins and Colorectal Cancer
Journal:
Current Genomics
Volume:
8
Page:
43-49
Author(s):
Lai Mao-De and Xu Jing
Targeting RAS Signaling Pathways in Juvenile Myelomonocytic Leukemia
Journal:
Current Drug Targets
Volume:
8
Page:
715-725
Author(s):
Christian Flotho, Christian Kratz and Charlotte M. Niemeyer
The Role of SHP-2 in Cell Signalling and Human Disease
Journal:
Current Enzyme Inhibition
Volume:
3
Page:
264-272
Author(s):
Hanna Mannell and Florian Krotz
Protein Tyrosine Phosphatases: Strategies for Distinguishing Proteins in a Family Containing Multiple Drug Targets and Anti-Targets
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1161-1181
Author(s):
Brian T. Hoffman, Melanie R. Nelson, Keith Burdick and Susan M. Baxter